Risk factors associated with low bone mineral density and childhood osteoporosis in a population undergoing skeletal growth: a cross-sectional analytic study

Other authors

Institut Català de la Salut

[Magallares B] Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Department of Rheumatology, Universitari Dexeus-Grupo Quirón Salud Hospital, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. [Cerdá D] Department of Rheumatology, Hospital Sant Joan Despí Moisès Broggi, Barcelona, Spain. [Betancourt J, Fraga G] Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Department of Pediatrics, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Park H, Codes-Méndez H] Department of Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. [Quesada-Masachs E] Department of Rheumatology, Universitari Dexeus-Grupo Quirón Salud Hospital, Barcelona, Spain. Unitat de Reumatologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [López-Corbeto M] Unitat de Reumatologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2025-08-21T08:37:37Z

2025-08-21T08:37:37Z

2025-05-23



Abstract

Bone fragility; Bone mineral density; Childhood osteoporosis


Fragilitat òssia; Densitat mineral òssia; Osteoporosi infantil


Fragilidad ósea; Densidad mineral ósea; Osteoporosis infantil


Background: Early identification of risk factors for low bone mass for chronological age (LBMca) and childhood osteoporosis (cOP) in patients undergoing skeletal growth is essential to mitigate long-term skeletal complications. cOP is diagnosed when LBMca (BMD Z-score ≤2) is accompanied by a clinically significant fracture history, or when vertebral fragility fractures are present. Methods: Patients under 21 years of age with at least one risk factor for LBMca (malabsorption syndrome, chronic inflammatory diseases, hematological diseases, endocrinopathies, drugs that affect bone metabolism, or insufficient calcium intake) were included. Data on fractures history and physical activity levels were collected. Spine and whole-body dual-energy x-ray absorptiometry (DXA) and vertebral morphometry were performed. Age-adjusted linear regression analysis evaluated associations between bone mineral density (BMD) and risk factors. Results: A total of 103 patients were included (mean age 9.8 years; 52.4% female), and 96.1% had more than two risk factors. The prevalence of LBMca was 10.5% and the prevalence of cOP was 4.8%. Vertebral BMD was positively associated with male sex. Whole body BMD was negatively associated with sedentary lifestyle and fracture history. Total body less head BMD showed negative associations with current steroid treatment, sedentary lifestyle, and history of fractures. Conclusions: Pediatric populations at risk of LBMca or cOP often have multiple risk factors, notably modifying ones such as physical inactivity. Up to 10.5% of children with risk factors present LBMca and 4.8% have an undiagnosed or unknown cOP. Longitudinal studies are warranted to understand the long-term impact of the identified risk factors, including age, sex, sedentary lifestyle, ethnicity and vitamin D status, on bone health.

Document Type

Article


Published version

Language

English

Subjects and keywords

Infants; Osteoporosi - Factors de risc; Densitometria òssia; Ossos - Malalties - Radiografia; Cos - Composició; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Radiography::Absorptiometry, Photon; PHENOMENA AND PROCESSES::Musculoskeletal and Neural Physiological Phenomena::Musculoskeletal Physiological Phenomena::Bone Density; PHENOMENA AND PROCESSES::Physiological Phenomena::Growth and Development::Morphogenesis::Embryonic and Fetal Development::Organogenesis::Musculoskeletal Development::Biomineralization::Bone Development; NAMED GROUPS::Persons::Age Groups::Child; DISEASES::Musculoskeletal Diseases::Bone Diseases::Bone Diseases, Metabolic::Osteoporosis; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::técnicas y procedimientos diagnósticos::diagnóstico por imagen::radiografía::absorciometría fotónica; FENÓMENOS Y PROCESOS::fenómenos fisiológicos nerviosos y musculoesqueléticos::fenómenos fisiológicos musculoesqueléticos::densidad ósea; FENÓMENOS Y PROCESOS::fenómenos fisiológicos::crecimiento y desarrollo::morfogénesis::desarrollo embrionario y fetal::organogénesis::desarrollo musculoesquelético::biomineralización::desarrollo óseo; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño; ENFERMEDADES::enfermedades musculoesqueléticas::enfermedades óseas::enfermedades óseas metabólicas::osteoporosis; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::estadística como asunto::probabilidad::riesgo::factores de riesgo

Publisher

Frontiers Media

Related items

Frontiers in Endocrinology;16

https://doi.org/10.3389/fendo.2025.1587985

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)